| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.6 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.6 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.6 |
| mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | rigosertib | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |